Literature DB >> 30603900

Prognostic relevance of low-grade versus high-grade FIGO IB1 squamous cell uterine cervical carcinomas.

Lars-Christian Horn1, Anne Katrin Höhn2, Bettina Hentschel3, Uta Fischer2,4, Karl Bilek4, Christine E Brambs5.   

Abstract

PURPOSE: Tumor grade is one of the more controversial factors with limited prognostic information in squamous cell carcinomas (SCC) of the uterine cervix.
METHODS: Histologic slides of 233 surgically treated cervical SCC (FIGO IB1) were re-examined regarding the prognostic impact of the WHO-based grading system, using the different degree of keratinization, categorizing the tumors in G1, G2 and G3 (conventional tumor grade).
RESULTS: 45.1% presented with well-differentiated tumors (G1), 29.2% with moderate (G2) and 25.8% with poor differentiation (G3). Tumor grade significantly correlated with decreased recurrence-free and overall survival. However, detailed analyses between G1- and G2-tumors failed to show any correlation with either recurrence-free or overall survival. G1- and G2-tumors were therefore merged into low-grade tumors and were compared to the high-grade group (G3-tumors). This binary conventional grading system showed an improved 5-years recurrence-free (low-grade: 90.2% vs. high-grade: 71.6%; p = 0.001) and overall survival rates (low-grade: 89.9% vs. high-grade: 71.1%; p = 0.001) for low-grade tumors. On multivariate analysis adjusted for lymph node metastasis, high-grade tumors represented a hazard ratio of 2.4 (95% CI 1.3-4.7) for reduced recurrence-free and 2.4 (95% CI 1.2-4.6) for overall survival. High-grade tumors showed a significantly higher risk for pelvic lymph node involvement [OR 2.7 (95% CI 1.4-5.5); p = 0.003]. The traditional three-tiered grading system failed to predict pelvic lymph node metastases.
CONCLUSION: A binary grading model for the conventional tumor grade (based on the degree of keratinization) in SCC of the uterine cervix may allow a better prognostic discrimination than the traditionally used three-tiered system.

Entities:  

Keywords:  Cancer; Cervix; Grading; Histopathology; Prognosis; Squamous cell; Survival; Treatment

Mesh:

Year:  2019        PMID: 30603900     DOI: 10.1007/s00432-018-2793-3

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  5 in total

Review 1.  [Revised German guidelines on the diagnosis and treatment of carcinoma of the uterine cervix-what's new for pathologists in 2021?]

Authors:  Lars-Christian Horn; Matthias W Beckmann; Markus Follmann; Martin C Koch; Monika Nothacker; Birgit Pöschel; Frederik Stübs; Dietmar Schmidt; Anne Kathrin Höhn
Journal:  Pathologie (Heidelb)       Date:  2022-02-21

2.  Evaluation of CD24 and CD44 as cancer stem cell markers in squamous cell carcinoma and epithelial dysplasia of the oral cavity by q- RT-PCR.

Authors:  Majid Mirhashemi; Narges Ghazi; Nasrollah Saghravanian; Ali Taghipour; Farnaz Mohajertehran
Journal:  Dent Res J (Isfahan)       Date:  2020-05-23

3.  Effect of multidisciplinary collaborative continuous nursing on the psychological state and quality of life of patients with cervical cancer.

Authors:  Dongfang Han; Dajun Wang; Jia Yang; Xiaomei Li
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

4.  Prognostic significance of poorly differentiated histology and impact of adjuvant chemotherapy in early squamous cell carcinoma of cervix uteri.

Authors:  Hui Luo; Hongxia Yao; Xinxin Xu; Zhen Li; Hongqin Zhao; Haiyan Zhu
Journal:  Cancer Med       Date:  2021-03-18       Impact factor: 4.452

5.  The diagnostic value of core needle biopsy in cervical cancer: A retrospective analysis.

Authors:  Massimiliano Lia; Lars-Christian Horn; Paulina Sodeikat; Michael Höckel; Bahriye Aktas; Benjamin Wolf
Journal:  PLoS One       Date:  2022-01-05       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.